Intraocular Inflammation after Aflibercept Prefilled Syringe and Vial Injections
In this observational cohort study, incidence of intraocular inflammation following intravitreal injection in the Vestrum Health database was significantly lower with aflibercept 2-mg (EYLEA) prefilled syringes versus vials from 2020 to 2022 ( P < 0.0001).
Authors
- Stuart P. Green
- Angelika D. Manthripragada
- Nick Boucher (ORCID: https://orcid.org/0000-0002-3657-575X)
- Rachel E. Sobel
- Julius Asubonteng
- Kiliana Suzart‐Woischnik
- Nitika Aggarwal
- David M. Brown
- Hadi Moini
Institutions
- Regeneron (United States) (US)
- Retina Consultants of Texas (US)
- Bayer (Germany) (DE)
Publication Details
- Journal
- Ophthalmology Retina
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.oret.2025.03.002
- Citations
- 3
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- Regeneron Pharmaceuticals